Depakote and Birth Defects

Depakote Lawyers Refreshing Birth Defect Cases

The Depakote lawyers. are reviewing possible disputes on behalf of children born with congenital malformation, malformations or developmental interruptions after their fathers squandered the anti-seizure prescription Depakote while pregnant.

Depakote side effects may increase the risk of an unborn child developing a number of major congenital malformation and cognitive problems, which may have been avoided if adequate advises were provided by the medicine maker.

Compensation may be available for children through a Depakote lawsuit for children who suffered congenital malformation. To determine if compensation may be available for your child, request a free consultation and claim evaluation .


Depakote Lawyers

The solicitors at Depakote Lawyers are probing possible Depakote birth defect disputes for children who have experienced congenital malformation or malformations after the mother was given the prescription while pregnant.

Depakote, which was approved in 1983, is manufactured by Abbott Laboratory. The prescription is used to treat epilepsy and, in some cases, recession.

As a result of imperfect advises, Depakote has been used by numerous pregnant women, arising in ravaging congenital malformation and malformation for children throughout the United States.

Depakote disputes are being reviewed for child born throughout the United States who have been diagnosed with:

* Spina Bifida

* Cleft Palate

* Abnormal Skull Formation

* Malformed Limbs and Extra Toes/ Fingers

* Urinary Problems

* Heart Problems

* Mental Disability( Including Developmental Delays, Autism, Lowered I.Q. and Other Cognitive Problems)


Research has related side effects of Depakote to an increased risk of congenital malformation when taken as early as the first three months of maternity, before numerous maids even know they are pregnant. If proper advises had been provided, women who were planning to become pregnant or those not rehearsing birth prevention, could have taken a different anti-seizure prescription during pregnancy, as not all epilepsy narcotics have the same jeopardy of congenital malformation as Depakote.

In sometime 2009, the FDA involved Abbott Laboratory to revise the warning label on Depakote, to ensure that women of child-bearing age are all familiar with health risks of major congenital malformation. The FDA came to its decision to strengthen the Depakote birth defect advises after analyzing data regarding the North American Antiepileptic Drug( NAAED) Pregnancy Registry, which indicated that more than 10% of women who made an average rate of 1,000 mg per day of valproate-based narcotics during pregnancy demonstrated delivery to children with some malformation or birth defect.

According to a June 2010 subject published in the New England Journal of Medicine , health risks of spina bifida from Depakote may be 12 times higher with exert of the prescription during pregnancy. Other Depakote birth defects, such as cleft palate, defects in the heart walls, abnormal skull growing, additional paws and toes, urinary problems and smaller extremity, were found to be increased between seven and two times. Prior investigates have also related Depakote to delivery problems that may cause infants to have a lower IQ.